Literature DB >> 19352614

Molecular mechanisms involved in NAFLD progression.

Mariano Malaguarnera1, Michelino Di Rosa, Ferdinando Nicoletti, Lucia Malaguarnera.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an emerging metabolic-related disorder characterized by fatty infiltration of the liver in the absence of alcohol consumption. NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), which might progress to end-stage liver disease. This progression is related to the insulin resistance, which is strongly linked to the metabolic syndrome consisting of central obesity, diabetes mellitus, and hypertension. Earlier, the increased concentration of intracellular fatty acids within hepatocytes leads to steatosis. Subsequently, multifactorial complex interactions between nutritional factors, lifestyle, and genetic determinants promote necrosis, inflammation, fibrosis, and hepatocellular damage. Up to now, many studies have revealed the mechanism associated with insulin resistance, whereas the mechanisms related to the molecular components have been incompletely characterized. This review aims to assess the potential molecular mediators initiating and supporting the progression of NASH to establish precocious diagnosis and to plan more specific treatment for this disease.

Entities:  

Mesh:

Year:  2009        PMID: 19352614     DOI: 10.1007/s00109-009-0464-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  171 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.

Authors:  G Leonarduzzi; A Scavazza; F Biasi; E Chiarpotto; S Camandola; S Vogel; R Dargel; G Poli
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

3.  Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

Authors:  Jörn M Schattenberg; Yongjun Wang; Rajat Singh; Raina M Rigoli; Mark J Czaja
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

4.  Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

Authors:  R G Boot; T A van Achterberg; B E van Aken; G H Renkema; M J Jacobs; J M Aerts; C J de Vries
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

5.  Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?

Authors:  P Bedossa; K Houglum; C Trautwein; A Holstege; M Chojkier
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

6.  Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.

Authors:  Ajay Duseja; Ashim Das; Radha Krishan Dhiman; Yogesh Kumar Chawla; Kiran T Thumburu; Sanjay Bhadada; Anil Bhansali
Journal:  Ann Hepatol       Date:  2007 Oct-Dec       Impact factor: 2.400

7.  Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice.

Authors:  Defeng Wu; Arthur Cederbaum
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

8.  Salicylate blocks lipolytic actions of tumor necrosis factor-alpha in primary rat adipocytes.

Authors:  Luxia Zu; Hongfeng Jiang; Jinhan He; Chong Xu; Shenshen Pu; Meifang Liu; Guoheng Xu
Journal:  Mol Pharmacol       Date:  2007-10-02       Impact factor: 4.436

9.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.

Authors:  Tony K T Lam; Hidenori Yoshii; C Andrew Haber; Elena Bogdanovic; Loretta Lam; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-10       Impact factor: 4.310

10.  The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.

Authors:  Carmela Loguercio; Alessandro Federico; Marco Trappoliere; Concetta Tuccillo; Ilario de Sio; Agnese Di Leva; Marco Niosi; Mauro Valeriano D'Auria; Rita Capasso; Camillo Del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

View more
  96 in total

1.  Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.

Authors:  Masayuki Nagahashi; Kazuaki Takabe; Runping Liu; Kesong Peng; Xiang Wang; Yun Wang; Nitai C Hait; Xuan Wang; Jeremy C Allegood; Akimitsu Yamada; Tomoyoshi Aoyagi; Jie Liang; William M Pandak; Sarah Spiegel; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

2.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

Review 3.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

Review 4.  Alternative macrophage activation and metabolism.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance.

Authors:  Wei-Ning Jiang; Dan Li; Tao Jiang; Jiao Guo; Yan-Fen Chen; Jie Wang; Yun Zhou; Chao-Yan Yang; Chun-Ping Tang
Journal:  Chin J Integr Med       Date:  2016-05-10       Impact factor: 1.978

6.  Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells.

Authors:  Shumin Qin; Jinjin Yin; Keer Huang
Journal:  Lipids       Date:  2016-06-07       Impact factor: 1.880

Review 7.  Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.

Authors:  Faisal Saeed Khan; Ijaz Ali; Ume Kalsoom Afridi; Muhammad Ishtiaq; Rashid Mehmood
Journal:  Hepatol Int       Date:  2016-06-07       Impact factor: 6.047

8.  Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.

Authors:  Fengxia Ge; Shengli Zhou; Chunguang Hu; Harrison Lobdell; Paul D Berk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 9.  Regulation of hepatic gene expression by saturated fatty acids.

Authors:  T Vallim; A M Salter
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-12       Impact factor: 4.006

Review 10.  Vitamin E and nonalcoholic fatty liver disease.

Authors:  Tommy Pacana; Arun J Sanyal
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-11       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.